A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

Clinical trial NCT05316688 · TERMINATED

Trial details

NCT number: NCT05316688
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Oral Cavity Squamous Cell Carcinoma Stage I Lip and Oral Cavity Cancer AJCC v8 Stage II Lip and Oral Cavity Cancer AJCC v8 Stage III Lip and Oral Cavity Cancer AJCC v8 Stage IVA Lip and Oral Cavity Cancer AJCC v8

Start date: 2024-04-17
Primary completion: 2025-09-09
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.